NDI-5001

· Otsuka Pharmaceutical Development & Commercialization, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NDI-5001, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study in Adult Males With X-linked Congenital Nephrogenic Diabetes Insipidus to Test the Effects of NDI-5001 Given for Multiple Days and to Test How NDI-5001 is Tolerated and Taken up in the Body [Phase 1]

See pricing